Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-02

Clinical Trial Update: Effect of Anti-interleukin 5 (IL5) Therapy on Sputum Cells and Cytokines [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of anti-IL-5 therapy on sputum cells and cytokines in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KU Leuven | Conditions: Asthma | Phase 4 | Status: COMPLETED